Reported Earlier, Humacyte Prices Public Offering Of 47,619,048 Common Shares At $1.05 Per Share Raising $50M To Fund Symvess Commercialization And Pipeline Development

뉴스 본문을 불러오고 있어요.

Reported Earlier, Humacyte Prices Public Offering Of 47,619,048 Common Shares At $1.05 Per Share Raising $50M To Fund Symvess Commercialization And Pipeline Development | 웨이프 WAPE

Reported Earlier, Humacyte Prices Public Offering Of 47,619,048 Common Shares At $1.05 Per Share Raising $50M To Fund Symvess Commercialization And Pipeline Development

기사 요약

관련 종목

댓글 —